Author
Listed:
- Roxane M. Pommier
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon
Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Amélien Sanlaville
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon)
- Laurie Tonon
(Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Janice Kielbassa
(Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Emilie Thomas
(Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Anthony Ferrari
(Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Anne-Sophie Sertier
(Plateforme de bioinformatique Gilles Thomas, Centre Léon Bérard)
- Frédéric Hollande
(The University of Melbourne, Victorian Comprehensive Cancer Centre)
- Pierre Martinez
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon)
- Agnès Tissier
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon)
- Anne-Pierre Morel
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon)
- Maria Ouzounova
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon)
- Alain Puisieux
(Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Equipe Labellisée Ligue contre le Cancer
Université de Lyon
Institut Curie, PSL Research University)
Abstract
Claudin-low breast cancers are aggressive tumors defined by the low expression of key components of cellular junctions, associated with mesenchymal and stemness features. Although they are generally considered as the most primitive breast malignancies, their histogenesis remains elusive. Here we show that this molecular subtype of breast cancers exhibits a significant diversity, comprising three main subgroups that emerge from unique evolutionary processes. Genetic, gene methylation and gene expression analyses reveal that two of the subgroups relate, respectively, to luminal breast cancers and basal-like breast cancers through the activation of an EMT process over the course of tumor progression. The third subgroup is closely related to normal human mammary stem cells. This unique subgroup of breast cancers shows a paucity of genomic aberrations and a low frequency of TP53 mutations, supporting the emerging notion that the intrinsic properties of the cell-of-origin constitute a major determinant of the genetic history of tumorigenesis.
Suggested Citation
Roxane M. Pommier & Amélien Sanlaville & Laurie Tonon & Janice Kielbassa & Emilie Thomas & Anthony Ferrari & Anne-Sophie Sertier & Frédéric Hollande & Pierre Martinez & Agnès Tissier & Anne-Pierre Mor, 2020.
"Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution,"
Nature Communications, Nature, vol. 11(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17249-7
DOI: 10.1038/s41467-020-17249-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17249-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.